Treatments |
Before treatment |
After first treatment |
After second treatment |
NSKE |
1.6 ± 0.57a |
1.33 ± 1.15bc |
1.0 ± 1.00b |
CLE |
1.6 ± 0.57a |
1.3 ± 0.57bc |
1.0 ± 0.00b |
BLE |
2.33 ± 0.57a |
1.6 ± 0.57b |
1.66 ± 0.57b |
NSKE+BLE |
2.0 ± 0.00a |
1.6 ± 0.57b |
1.33 ± 1.15bc |
CLE + BLE |
1.3 ± 0.57a |
1.0 ± 1.00bc |
0.66 ± 1.15bc |
NSKE +CLE |
2.0 ± 1.00a |
1.3 ± 0.57bc |
0.33 ± 0.57c |
Diazinon 60% EC |
1.6 ± 0.57a |
0.0 ± 0.00c |
0.0 ± 0.00c |
Control |
1.66 ± 0.57a |
3.3 ± 0.57a |
3.0 ± 1.00a |
Values are mean ± standard deviation of three replications. Similar alphabets within
the column was statistically not significant (p>0.05; LSD). |